BIOTEST BIOTECH released its semi-annual performance, with a net profit attributable to the parent company of 12.4 million yuan, a year-on-year decrease of 82.82%

Zhitong
2025.08.28 08:40
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, BIOTEST BIOTECH disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 203 million yuan, a year-on-year decrease of 23.91%; net profit attributable to the parent company was 12.4 million yuan, a year-on-year decrease of 82.82%; net profit excluding non-recurring items was 6.83 million yuan, a year-on-year decrease of 90.25%; basic earnings per share were 0.07 yuan

According to the Zhitong Finance APP, BIOTEST BIOTECH (688767.SH) disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 203 million yuan, a year-on-year decrease of 23.91%; net profit attributable to the parent company was 12.4 million yuan, a year-on-year decrease of 82.82%; net profit excluding non-recurring gains and losses was 6.83 million yuan, a year-on-year decrease of 90.25%; basic earnings per share were 0.07 yuan

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.